Literature DB >> 21952607

Hypocomplementemic urticarial vasculitis syndrome: a rare cause of basilar panacinar emphysema.

Akshat C Pujara1, Tan-Lucien H Mohammed.   

Abstract

Hypocomplementemic urticarial vasculitis syndrome (HUVS) is a rare condition characterized by an immune complex-mediated disruption of multiple organ systems. Pulmonary involvement is a major cause of morbidity and mortality in patients with HUVS. HUVS has been described by clinical, histological, and laboratory findings. However, the role of radiography in the diagnosis and management of HUVS has not been established. We examine computed tomography findings in a patient with HUVS and explore the potential of thoracic computed tomography imaging to augment the management of HUVS by serving as a diagnostic tool and marker of disease severity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21952607     DOI: 10.1097/RTI.0b013e31822770fb

Source DB:  PubMed          Journal:  J Thorac Imaging        ISSN: 0883-5993            Impact factor:   3.000


  3 in total

Review 1.  Pulmonary vasculitis: diagnosis and endovascular therapy.

Authors:  Kiran Batra; Murthy Chamarthy; Rodrigo Caruso Chate; Kirk Jordan; Fernando Uliana Kay
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

2.  Pulmonary Low Attenuation Areas on CT in ANCA-associated Vasculitis: A quantitative and semi-quantitative analysis correlated with pulmonary function testing for obstructive airway disease.

Authors:  Christian W Cox; Brian J Bartholmai; Misbah Baqir; Jennifer R Geske; Ulrich Specks
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-12-16       Impact factor: 0.670

3.  Diffuse alveolar haemorrhage associated with subsequent development of ANCA positivity and emphysema in three young adults.

Authors:  Anna Stainer; Alex Rice; Anand Devaraj; Joseph Luke Barnett; Jacqueline Donovan; Maria Kokosi; Andrew Gordon Nicholson; Tom Cairns; Athol Umfrey Wells; Elisabetta Augusta Renzoni
Journal:  BMC Pulm Med       Date:  2019-10-24       Impact factor: 3.320

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.